Tamiflu Reduces The Number Of Cases Of Pneumonia In 'Swine Flu' Patients

Tamiflu Reduces The Number Of Cases Of Pneumonia In 'Swine Flu' Patients.
When entranced peremptorily after the onset of symptoms, the antiviral stimulant Tamiflu seems to have protected otherwise healthy swine flu patients from contracting pneumonia during the 2009 H1N1 pandemic, Chinese researchers say paurush. Tamiflu may also have shortened the interval that patients were contagious and reduced the duration of their fevers, the check in team said.

However, reporting in the Sept 29 young of 'bmj dot com', the study authors stressed that their findings should be interpreted with caution given that the conclusions are based on an after-the-fact examination and on a pool of patients not uniformly given chest X-rays at the time of illness acxion. The boning up team, led by Dr Weizhong Yang and Dr Hongjie Yu from the Chinese Center for Disease Control and Prevention in Beijing, note that in 2009 the fast-spreading influenza A (H1N1) virus killed more than 18000 subjects in over 200 countries.

Prior scrutinization has suggested that patients who quaff antiviral medications within two days of experiencing seasonal flu symptoms may exhibit a less severe and shorter-lasting illness and may also reduce their risk for complications. To gauge to what degree this might be dedicated for healthy patients with a mild form of H1N1, the research team reviewed the medical records of nearly 1300 Chinese patients diagnosed with the infection in 2009.

The ordinary age of the patients was 20. More than three-quarters were given Tamiflu within a median of three days following the assault of symptoms, and 920 of the patients underwent reinforcement chest X-rays. Just 12 percent of those X-rayed had signs of pneumonia, the researchers observed. None of them needed tariff for intensive care, and none required mechanical ventilation.

Even after accounting for age, gender, influenza vaccine and antibiotic curing history, the authors concluded that Tamiflu remedying appeared to offer significant protection against pneumonia. This protective effect was appearing in all patients who took Tamiflu, even those who took it more than 48 hours after symptom onset, but those who took the medication within 48 hours sage shorter fevers and were contagious for a shorter time eyelasticity age defying eye therapy withdraw. The Chinese line-up nonetheless called for more follow-up research to investigate the potential benefits of Tamiflu for swine flu.